Ozempic Weight Loss Timeline: Week-by-Week Results for Wegovy, Zepbound & Mounjaro (2026 Guide)

Based on the STEP and SUSTAIN clinical trials and large real-world datasets, the average person on semaglutide (Ozempic/Wegovy) at a full therapeutic dose loses roughly:

Tirzepatide (Mounjaro/Zepbound) runs about 30–40% ahead of semaglutide at every milestone — most people hit 20% total body weight loss by month 15. Wegovy is the same molecule as Ozempic but dosed higher for weight loss, so its curve is slightly steeper than Ozempic's after month 3.

Your personal numbers can vary widely from these averages based on starting weight, dose, diet, activity, sleep, muscle mass, and genetics. Below is what's actually happening at each stage — and why the scale sometimes lies.

Most people notice appetite suppression within 24–72 hours of the first dose. Food noise quiets down, portions naturally shrink, and cravings for hyperpalatable food (chips, sweets, alcohol) often drop first. On the scale, expect 1–3 lbs down by day 7 — mostly water and reduced stomach contents, not fat.

This is also when mild nausea, burps, and fatigue peak. That's not the medication failing; it's your gut adjusting to slower emptying. Sip water constantly, get electrolytes in early, and eat smaller, protein-forward meals.

Ozempic starts at 0.25 mg for four weeks — a starter dose designed to build tolerance, not drive weight loss. Even so, most people are down 4–7 lbs by the end of week 4. This is the "honeymoon" phase where every week shows visible progress on the scale.

Wegovy and Zepbound follow a similar 4-week titration schedule (Wegovy starts at 0.25 mg, Zepbound at 2.5 mg). Mounjaro's 2.5 mg starter dose often produces slightly faster early losses than Ozempic's 0.25 mg.

At week 5, most people move up to 0.5 mg of Ozempic (or 5 mg of Zepbound). This is when weekly losses of 1–2 lbs become consistent, and when non-scale wins — looser clothes, better bloodwork, less joint pain — start stacking up. Total loss by end of month 2 typically sits at 8–12 lbs.

Watch for the first "whoosh": a stall of 5–10 days followed by a sudden 3–4 lb drop. This is normal water-and-fat cell rebalancing and happens throughout your journey.

By week 12, clinical trials show the average semaglutide user has lost 6–8% of starting body weight — roughly 12–18 lbs for a 200 lb starting weight. Tirzepatide users typically hit 8–11% (16–22 lbs) at the same mark.

This is a common decision point with your prescriber. If losses have been slow, you may titrate up to Ozempic 1 mg or Zepbound 7.5–10 mg. If side effects are still rough, you may hold the current dose longer. Both are valid — the goal is sustainable loss, not the fastest possible drop.

This is the workhorse phase. Weekly losses average 1–2 lbs on semaglutide and 1.5–2.5 lbs on tirzepatide. Total loss by month 6 typically reaches 10–12% of body weight on Ozempic/Wegovy and 15% on Mounjaro/Zepbound.

You'll also likely hit your first real plateau — a 2–4 week stall where the scale barely moves. This is not a sign the medication has stopped working. It's your metabolism recalibrating to a lower body weight (adaptive thermogenesis) and, often, water retention from a new exercise routine. Push through: measure your waist, take progress photos, and trust the process.

Weight loss slows in the second half of year one — not because the drug is weaker, but because you're closer to a new, lower body weight where energy in and energy out balance again. Most semaglutide users add another 4–7% (roughly 8–15 lbs) between months 6 and 12. Tirzepatide users add 5–8% in the same window.

By month 12, average total loss is 14–15% on Wegovy and 20–22% on Zepbound. Ozempic users (typically dosed for diabetes rather than weight loss) average slightly less.

The STEP-1 trial showed semaglutide users plateaued at around 68 weeks (17 months) at 15% total body weight loss. SURMOUNT-1 showed tirzepatide users plateaued closer to 72 weeks (17 months) at 20–22%. That plateau is real and expected — it's your body finding equilibrium at a new set point.

Staying on the medication indefinitely is what preserves the loss. In extension studies, people who stopped semaglutide regained about two-thirds of the lost weight within a year. If you plan to taper off, do it slowly with dietary and strength-training habits already in place.

All four medications work through the same GLP-1 receptor pathway, but their weight loss curves differ meaningfully:

Tirzepatide's edge comes from activating both GLP-1 and GIP receptors, which produces stronger appetite suppression and better metabolic effects than GLP-1 alone. That said, semaglutide is often better tolerated by people sensitive to nausea.

The number on the scale is one of the least accurate measures of fat loss on a GLP-1. Three things regularly mask real progress:

Weigh yourself once a week, same day, same conditions. Track waist and hip measurements monthly. Take progress photos every 4 weeks. These three data points together tell you far more than a daily scale.

The people who hit — and hold — the top of the average range have a few habits in common:

When does Ozempic start working? Appetite suppression begins within 24–72 hours of the first dose. Meaningful weight loss (2–3% of body weight) usually shows up by week 4.

How much weight will I lose on Ozempic in a month? On average, 4–7 lbs in the first month at the starter dose, and 6–10 lbs/month once you reach a therapeutic dose.

How much weight will I lose on Ozempic in 3 months? Roughly 12–18 lbs, or 6–8% of starting body weight, based on clinical trial averages.

Is Zepbound faster than Ozempic? Yes. Head-to-head data (SURMOUNT-5) showed tirzepatide produced ~50% more weight loss than semaglutide at 72 weeks.

What's a normal Ozempic plateau? A 2–4 week stall after losing 5–10% of body weight is expected. A plateau lasting 6+ weeks warrants a dose or habit review with your prescriber.

Do I lose weight faster on Ozempic if I skip meals? No. Under-eating drives muscle loss, fatigue, and rebound eating. Aim for 3 protein-forward meals a day, even when appetite is low.

How long can I stay on Ozempic? Indefinitely, based on current safety data. Stopping usually leads to significant regain, so most prescribers view GLP-1s as long-term treatment for a chronic condition — not a short-term diet.